润达医疗：预计2025年上半年净利润亏损1.3亿元-1.09亿元

Core Viewpoint - RunDa Medical (603108) is expected to report a net loss attributable to shareholders of the parent company ranging from -130 million to -109 million yuan for the first half of 2025, indicating a decline compared to the same period last year [1] Financial Performance - The projected net profit attributable to shareholders, excluding non-recurring gains and losses, is expected to be between -145 million and -121 million yuan for the first half of 2025 [1]